date:Jan 04, 2013
offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.
We wish our colleagues at AbbVie continued success as they become part of a new, independent company that is already making a significant difference, focusing on highly specialized, market-leading therapies for some of the world's most difficult-to-treat diseases, said Miles D. White, chairman and chief executive officer, Abbott.
Abbott has taken the most transformative action in its 125-year history,